Back to Results
First PageMeta Content
Cell cycle / Tumor suppressor genes / Transcription factors / Astex / Cyclin-dependent kinase / P16 / Retinoblastoma protein / Cyclin / Melanoma / Biology / Cell biology / Proteins


Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec
Add to Reading List

Open Document

File Size: 11,38 KB

Share Result on Facebook

City

Cambridge / /

Company

GlaxoSmithKline / Johnson & Johnson / Novartis / AstraZeneca / Astex Therapeutics Astex / Astex Therapeutics / /

Country

United Kingdom / /

Event

Business Partnership / /

IndustryTerm

biotechnology / pharmaceutical / cancer therapies / /

MedicalCondition

cancers / tumor / melanoma / liposarcoma / cancer / retinoblastoma / carcinomas / novel cancer / pRb positive cancers / /

MedicalTreatment

cancer therapies / /

Person

Harren Jhoti / /

Position

Chief Executive Officer / /

Product

endsAbout LEE011 LEE011 / LEE011 / /

Technology

drug discovery / /

URL

www.astex-therapeutics.com / /

SocialTag